DS Healthcare Announces Its Long Awaited Marketing Initiative For Women

Pompano Beach, Fla., Dec. 22, 2014 — DS Healthcare Group, Inc. (DSKX), a leading developer of personal care products, launched a new marketing campaign to introduce its technology based products to a broader demographic. A striking model is shown in a laboratory environment to demonstrate the confluence of science and beauty.

“Our products represent the most groundbreaking advances in science and technology. We don’t want consumers to only see our products as a solution they turn to when there is a problem, we want them to see DS products as a part of healthy lifestyle that leads to better appearance and well being. As demonstrated in countless volunteers, our hair care products give users better-looking hair and a healthier scalp. For those who desire the best hair, we have the solution and it always comes from scientific advances, not glitzy bottles from the latest trends,” stated DS Healthcare President and CEO Daniel Khesin. “Since a substantial portion of revenue in this segment comes from female shoppers, we think this campaign will raise awareness about the significant benefits offered by our products and that they are not just for people suffering with thinning hair,” Khesin added.

In a consumer perception study Revita shampoo, the company’s flagship product was compared against many popular brands for its cosmetic benefits, in all cases Revita was preferred by hair dressers and users, even against many higher-priced products that otherwise don’t have any of the many additional benefits offered by DS topical products. A summary of this study can be seen in this video.

The images from the new campaign can be seen here.

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects.

For more information on DS Health Group’s flagship brand, visit www.dslaboratories.com

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies, and are generally preceded by words such as “future,” “plan” or “planned,” “expects,” or “projected.” These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company’s control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov

For more information contact:

Daniel Khesin
President and CEO
DS Healthcare Group, Inc.

Distributed by Microcap Headlines, Inc.

Media Contact
Company Name: Microcap Headlines, Inc.
Contact Person: Nicole Peccia
Email: howard@microcapheadlines.com
Phone: (877) 283-6422
Country: United States
Website: www.microcapheadlines.com